All times are in Eastern Time unless otherwise noted.
-
-
-
FDA Task Force Meeting
Virtual EventAdd to Calendar Use the following links to add to your personal calendar: Google Apple Office 365 Outlook iCal MS Teams Yahoo
-
Op-ed Happy Hour Workshop
Virtual EventOp-ed Happy Hour Workshop 📅 Recurring Event: Every 4th Wednesday of the month 🕗 Time: 8:00 PM - 9:00 PM (ET) 🔗 Registration: Register via Zoom Event Overview Join Jennifer Obel, MD (prior freelance journalist for the Washington Post and Spokesperson for ASCO) for a hands-on training for DFA advocates who want to learn how...
-
-
Physicians Needed: Medicolegal Immigration Advocacy
Virtual EventSession Overview Participants will gain a deeper understanding of the different immigration pathways and legal statuses that shape the experiences of immigrant and refugee communities. The session will also demystify the pathways to becoming a civil surgeon and the crucial roles these medical professionals play in supporting immigrant health and documentation needs. Finally, we’ll examine...
-
-
Access to Affordable Care Subcommittee Meeting
Add event to calendar Apple Google Office 365 Outlook Web Outlook Yahoo
-
-
FDA Task Force Meeting
Virtual EventAdd to Calendar Use the following links to add to your personal calendar: Google Apple Office 365 Outlook iCal MS Teams Yahoo
-
Why Physicians Should Pay Attention to the FDA
Virtual EventSession Overview Our upcoming virtual event will explore why today’s clinicians need to stay informed about FDA actions, and how regulatory decisions directly influence clinical practice and patient care. The session will examine the growing controversy surrounding industry-aligned “expert panels” FDA-appointed groups that can be used instead of traditional Advisory Committees, FDA appointed groups that...
-
-
-
Access to Affordable Care Subcommittee Meeting
Add event to calendar Apple Google Office 365 Outlook Web Outlook Yahoo
-
Prescription Coverage in a Changing Policy Landscape
Virtual EventSession Overview This session will explore recent policy changes and announcements affecting GLP-1 therapies and emerging prescription drug initiatives, including TrumpRx. Our speaker will examine how these developments may influence insurance coverage, patient access, and prescribing considerations. The discussion will place these changes in the broader context of evolving coverage and affordability pressures, highlighting potential...
